HDAC inhibitors target anti-apoptotic proteins and induce TRAIL mediated apoptosis in resistant cancer cells by enhancing surface expression of TRAIL receptors and re-distribution of TRAIL receptors into lipid rafts (reviewed by [73]). The gene discussed is TNFSF10; the disease is cancer.